Mark Faulkner v Vollin Holdings Ltd

JurisdictionEngland & Wales
JudgeMr Justice Adam Johnson
Judgment Date31 March 2021
Neutral Citation[2021] EWHC 787 (Ch)
CourtChancery Division
Docket NumberCase No: CR-2018-005055
Date31 March 2021

[2021] EWHC 787 (Ch)

IN THE HIGH COURT OF JUSTICE

BUSINESS AND PROPERTY COURTS OF ENGLAND & WALES

INSOLVENCY AND COMPANIES LIST

COMPANIES COURT

IN THE MATTER OF COMPOUND PHOTONICS GROUP LIMITED

AND IN THE MATTER OF COMPOUND PHOTONICS UK LIMITED

AND IN THE MATTER OF THE COMPANIES ACT 2006

7 Rolls Buildings

Fetter lane, London

EC 4A 1NL

Before:

Mr Justice Adam Johnson

Case No: CR-2018-005055

Between:
(1) Mark Faulkner
(2) Jonathan Sachs
(3)-(70) The Minorities (As listed in Schedule 1 to the Petition)
Petitioners
and
(1) Vollin Holdings Limited
(2) Minden Worldwide Limited
(3) Compound Photonics Group Limited
(4) Compound Photonics UK Limited
(5) Aldon Investments Limited
Respondents

Mr Robin Hollington QC and Mr Adrian Pay (instructed by Mishcon de Reya LLP) for the Petitioners

Mr Andreas Gledhill QC, Mr Donald Lilly, Mr Timothy Lau and Zara McGlone (instructed by Allen & Overy LLP) for the First, Second and Fifth Respondents

The Third and Fourth Respondents did not appear and were not represented

Hearing dates: 9, 10, 11, 12, 13, 16, 17, 18, 19, 20, 23, 24, 25, 26, 27, 30 November 2020, 1, 2, 3 and 4 December 2020

Approved Judgment

I direct that pursuant to CPR PD 39A para 6.1 no official shorthand note shall be taken of this Judgment and that copies of this version as handed down may be treated as authentic.

Mr Justice Adam Johnson Mr Justice Adam Johnson

CONTENTS

Paragraph

I

Introduction & Outline

1

II

The Principal Characters

10

III

The Scope of the Trial

17

IV

The Evidence

18

The Petitioners' Witnesses

19

The Respondents' Witnesses

21

The Experts

29

V

Factual Background

31

Compound Photonics Prior to 2010

31

Vollin's 2010 Investment

32

2010–2013

50

The 2013 Constitution

54

The 2013 SHA

56

The 2013 Articles

67

Newton Aycliffe

77

The November 2013 Business Plan

81

2014: The Minden Investment

85

The World Mobile Congress

89

2015: Vollin becomes concerned

94

Mr Bolger's Visit to Phoenix

100

Alternative Funding Source

105

Presentation to the Minorities/Year-end 2015

108

Early 2016: the P1 Prototype

112

9–14 March 2016

126

Management of CPGL: 13 April Investor Update Meeting

162

Newton Aycliffe & the Last Time Buy Notice

167

Mr Faulkner

174

24 May 2016 Investor Update Meeting

183

Mr Faulkner's “Lightbulb moment”

184

Kaiam Corp.

187

Mr Faulkner: Lunch at the Shard with Mr Bolger

194

4 July 2016: Meeting with Selex in Edinburgh

199

Dr Lind Resignation

204

Ongoing discussions with Kaiam

205

Mr Faulkner Again

211

11 August 2016: Kaiam Visit to Newton Aycliffe

221

Early August 2016: Mr Faulkner's solvency concerns

224

15 August 2016: Investor Update Meeting

231

The clause 20.1 SHA issue

239

Mr Faulkner's Circular

251

Mr Bolger's Alleged Threat

256

Finalising the Accounts and Mr Faulkner's Visit to Newton Aycliffe

259

Mr Faulkner is Removed

266

Newton Aycliffe: Revisited

276

ATREG

284

Newton Aycliffe: Considering the Options

289

The Sale to Kaiam

300

The Intended Kaiam Acquisition of Newton Aycliffe is Announced

316

The Sale to Kaiam Completes

320

Re-Sale of Newton Aycliffe by Kaiam

321

VI

The Petitioners' Case in Outline

334

VII

Applicable Legal Principles

338

Defining The Parties' Bargain

340

Contractual Obligations of Good Faith

348

Good Faith Clauses: Scope

350

Good Faith Clauses: Content

354

Directors Duties

371

Prejudice

381

VIII

The Parties' Bargain in this Case and the Role of the Good Faith Clause

382

IX

The Removal of Dr Sachs

401

The Investors

402

The Directors

420

X

The Period After Dr Sachs' Departure: Summary

431

XI

Management of CPGL

438

The Investors

439

The Directors: Mr Bolger as a Shadow Director?

462

The Directors

469

Article 17.1 – disclosure of interests

473

CA s171(a) – duty to act in accordance with constitution

477

CA s171(b) – duty to exercise powers for proper purposes

478

CA s.172 – duty to promote success of the company

479

CA s173 – duty to act independently

486

CA s175/Art 17.2 – duty to avoid conflicts of interest

487

XII

Change of Business

492

XIII

Removal of Mr Faulkner

502

The Investors

503

The Directors

511

XIV

Appointments of Further Directors

512

XV

Failure to Keep Minorities Informed

528

XVI

Newton Aycliffe

532

Was there a Sale at an Undervalue?

534

Mr Indge's Approach

540

Mr Mackie's Approach

544

Discussion & Conclusions

549

The Investors

569

The Directors

575

Article 17.1 – disclosure of interests

577

CA s171(a) – duty to act in accordance with constitution

578

CA s171(b) – duty to exercise powers for proper purposes

579

CA s172 – duty to promote success of the company

580

CA s173 – duty to act independently

587

CA s175/Art 17.2 – duty to avoid conflicts of interest

588

XVII

Conclusion

592

I Introduction

1

This is the hearing of an unfair prejudice petition brought under section 994 of the Companies Act 2006.

2

The Petitioners are minority shareholders in Compound Photonics Group Limited (“ CPGL”). The First Petitioner, Mr Faulkner, is a former director and chairman of CPGL, and the Second Petitioner, Dr Sachs, is also a former director and CEO of CPGL. The remaining Petitioners are individual investors who were introduced to CPGL, and to Dr Sachs, by Mr Faulkner, in his former role as an independent financial adviser. These Petitioners have been referred to as “ the Minorities” although in point of fact Dr Sachs and Mr Faulkner are also minority shareholders in CPGL.

3

The business of CPGL, and of the Compound Photonics Group, grew out of Dr Sachs' academic research into gallium arsenide and liquid crystal technology. The business vision was to use this technology to revolutionise the market in projectors. The dispute between the parties arises largely out of Dr Sachs' efforts to realise that vision, through the medium of CPGL and its associated companies, in the period between 2010 and early 2016.

4

The Second and Fifth Respondents, Minden Worldwide Limited (“ Minden”) and Aldon Investments Ltd (“ Aldon”) are the present majority shareholders in CPGL. Aldon is the successor to another company, Vollin Holdings Limited (“ Vollin”). Vollin and Minden were the majority shareholders at the times relevant to these proceedings. During the trial, they came to be referred to as “ the Investors”, and I will adopt that description in this Judgment.

5

Vollin and Aldon are part of an investment structure of which the beneficial owners are Dr Alexander Abramov and Dr Alexander Frolov, two Russian businessmen who made substantial sums on the public listing of EVRAZ plc, a mining and metals business with interests in Russia, North America and elsewhere. Together Dr Abramov and Dr Frolov hold approximately 29% of the issued shares in EVRAZ plc.

6

Minden is part of an investment structure of which the Israeli-Russian businessman Mr Roman Abramovich is the beneficial object. He too is the owner of a 29% stake in EVRAZ plc.

7

The Petitioners make many detailed complaints, but in outline their case is a simple one. They say that they have been unfairly prejudiced because it was agreed that Dr Sachs and Mr Faulkner would remain involved in the management of CPGL, but in fact have been excluded – in the case of Dr Sachs in March 2016 and in the case of Mr Faulkner in October 2016. Moreover, say the Petitioners, in all periods after Dr Sachs' exclusion, the agreed-upon constitution of CPGL, as set out in its articles and a corresponding shareholders agreement, has effectively been ignored by the Investors and those associated with them, including in particular their nominated directors. This has resulted in further instances of unfair prejudice, arising both from breaches of the shareholders' agreement and the articles, and also from breaches by the Vollin and Minden nominee directors of the duties owed by them under the Companies Act 2006. Among the allegations made, a particularly important one concerns the alleged sale at an undervalue of a property known as Newton Aycliffe, which was owned by a subsidiary of CPGL, Compound Photonics UK Limited (“ CPUK”), the Fourth Respondent in these proceedings.

8

The Investors – who have also been referred to from time-to-time as the Active Respondents – deny all these allegations of unfair prejudice. Their basic point is that they invested huge sums in the business over many years in order to support Dr Sachs in realising his vision, but after long delays and a series of failures, they lost faith in Dr Sachs and entirely reasonably asked him to resign, which he agreed to do. They removed Mr Faulkner from the business by exercise of their majority vote after it became clear that his role as director and Chairman of CPGL was redundant and he had begun to behave in an erratic and unpredictable manner which was damaging to CPGL. They say that at all times they and their nominee directors acted in good faith, and so were not in breach of any provisions of the relevant shareholders agreement or, in the case of the...

To continue reading

Request your trial
1 cases
  • Mark Faulkner v Vollin Holdings Ltd
    • United Kingdom
    • Court of Appeal (Civil Division)
    • 21 October 2022
    ...APPEAL FROM THE HIGH COURT OF JUSTICE BUSINESS AND PROPERTY COURTS OF ENGLAND AND WALES COMPANIES COURT (ChD) Mr. Justice Adam Johnson [2021] EWHC 787 (Ch) Royal Courts of Justice Strand, London, WC2A 2LL Andreas Gledhill KC and Donald Lilly (instructed by Allen & Overy LLP) for the Appella......
1 firm's commentaries
  • Contractual Duties Of Good Faith: Court Of Appeal Confirms Context Is King
    • United Kingdom
    • Mondaq UK
    • 30 November 2022
    ...had breached the contractual good faith obligation and unfairly prejudiced the minority shareholders: Faulkner v Vollin Holdings Ltd [2021] EWHC 787 (Ch). In interpreting the good faith clause, the High Court followed Unwin v Bond [2020] EWHC 1768 (Comm) in concluding that once a party is s......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT